| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/2012 | CN101791314B Application of crocin in preparing hypnotic drug |
| 01/04/2012 | CN101791312B Use of tetrahydroisoquinoline derivatives |
| 01/04/2012 | CN101780145B Medical stone mineral health-care product |
| 01/04/2012 | CN101780099B Meglumine adenosine cyclophosphate composite medicament |
| 01/04/2012 | CN101773553B Semiaquilegia root extract, preparation method and application thereof |
| 01/04/2012 | CN101773551B External-use medicine composition of traditional Mongolian medicine for curing soft tissue injury |
| 01/04/2012 | CN101768124B Medicine crystal, preparation method and purpose thereof |
| 01/04/2012 | CN101756897B Clindamycin hydrochloride injection and preparation method thereof |
| 01/04/2012 | CN101747308B Molecular modification method for enhancing biological activity of procyanidine |
| 01/04/2012 | CN101736003B Japanese blood fluke miRNAs and applications thereof |
| 01/04/2012 | CN101735193B 9-anthranone spiro lactone compound and preparation method and application thereof |
| 01/04/2012 | CN101735168B P-sulfamyl benzylidene cyclic ketone compounds, preparation method and application thereof |
| 01/04/2012 | CN101732613B Simple and quick-acting bone-setting medicament and preparation process thereof |
| 01/04/2012 | CN101732301B Application of chlorogenic acid in preparing medicines for preventing and curing senile dementia |
| 01/04/2012 | CN101732286B Voglibose film and preparation method thereof |
| 01/04/2012 | CN101716320B Externally applied medical composition for treating orthopedic diseases and preparation method thereof |
| 01/04/2012 | CN101716159B Stable lansoprazole tablet and preparation method thereof |
| 01/04/2012 | CN101703482B Galanthamine long-acting release injectable microsphere composite and preparation method thereof |
| 01/04/2012 | CN101664403B Medicinal composition for treating cancer and signal transduction path thereof |
| 01/04/2012 | CN101658498B Freeze-drying manufactured product of cytidine triphosphate disodium and arginine and preparation method thereof |
| 01/04/2012 | CN101632662B Sirolimus preparation and preparation process thereof |
| 01/04/2012 | CN101618164B Pharmaceutical composition for curing rheumatoid arthritis |
| 01/04/2012 | CN101607070B Pharmaceutical composition for treating heart cerebrovascular disease |
| 01/04/2012 | CN101607035B Pharmaceutical composition for treating acute bronchitis in children |
| 01/04/2012 | CN101591333B Method for purifying pseudomonas acid A |
| 01/04/2012 | CN101590071B Application of icariin in preparing medicaments for treating acute cerebral infarction |
| 01/04/2012 | CN101588800B A method of administering an antitumor compound |
| 01/04/2012 | CN101564398B Multivitamin soft capsule and preparation method thereof |
| 01/04/2012 | CN101559198B Medicament for protecting joints and soft tissues |
| 01/04/2012 | CN101554472B Novel medical compound being capable of synergetically suppressing growth of tumors |
| 01/04/2012 | CN101543632B Anti-tumor prodrug having accurate structure and taking novel amphipathic polymer as carrier and synthetic method thereof |
| 01/04/2012 | CN101541323B Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels |
| 01/04/2012 | CN101528708B Indazole derivatives useful as l-cpt1 inhibitors |
| 01/04/2012 | CN101525314B Dihydropyridine calcium antagonist compound, preparation method and medicinal application thereof |
| 01/04/2012 | CN101524358B Medical application of psuedo-ginsenoside F11 |
| 01/04/2012 | CN101522693B Novel 5,7-disubstituted [1, 3] thiazolo [4, 5] pyrimidin-2 (3h)-amine deirvatives and their use in therapy |
| 01/04/2012 | CN101511845B Spiro antibiotic derivatives |
| 01/04/2012 | CN101445544B Method for preparing ginsenoside Rb<1> |
| 01/04/2012 | CN101440091B Ritonavir water-soluble derivatives, synthesizing method and use thereof |
| 01/04/2012 | CN101439041B Chinese medicine granule containing breviscapine and preparation method thereof |
| 01/04/2012 | CN101439027B Effervescent tablet containing L-carnitine-L-tartrate |
| 01/04/2012 | CN101428027B Medicament composition for preventing and treating thrombosis |
| 01/04/2012 | CN101410115B Compositions containing riboflavin and sesamin-class compounds |
| 01/04/2012 | CN101385713B Preparation method of lipoic acid lipid nano-particles |
| 01/04/2012 | CN101385696B Sodium alginate microspheres blood vessel suppository containing etoposide and preparation method and uses thereof |
| 01/04/2012 | CN101384246B External preparation for skin containing flavanone derivative |
| 01/04/2012 | CN101379049B Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same |
| 01/04/2012 | CN101372475B Aromatic heterocyclic substituted acardite derivative and use thereof |
| 01/04/2012 | CN101370793B Novel N-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor CCR4 |
| 01/04/2012 | CN101347502B Effective component of selfheal and preparation and use thereof |
| 01/04/2012 | CN101347468B Effective component of common camptotheca fruit and preparation as well as use thereof |
| 01/04/2012 | CN101347434B Medicament composition containing renin inhibitor and acidum folicum compound and uses thereof |
| 01/04/2012 | CN101347422B Uses of salvianolic acid A in preventing and/or treating diabetes and complication |
| 01/04/2012 | CN101342155B (R,R)-formoterol inhalation dust cloud agent and preparation method thereof |
| 01/04/2012 | CN101313900B Hydroxy fatty acid oligomer and application in regulating calcium ion concentration in cell |
| 01/04/2012 | CN101289444B Pyrimidine derivate and medicinal use thereof |
| 01/04/2012 | CN101288667B Application of chrysanthenone in preparing drug for treating coronary heat disease |
| 01/04/2012 | CN101255121B Preparation technique of lysine rhein and use thereof in tumour therapy |
| 01/04/2012 | CN101248078B Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 01/04/2012 | CN101244055B Application of oroxylin in pharmacy |
| 01/04/2012 | CN101239964B 15-oxospiramilactone and its medicament composition, preparation method and application |
| 01/04/2012 | CN101239936B Antineoplastic sulfur-containing alkannin and naphthoquinones derivatives |
| 01/04/2012 | CN101219125B Cold water dispersion type xanthophyll micro-capsule and its preparing method |
| 01/04/2012 | CN101209264B Total toadpoison lactones extraction with anti-tumor function, preparation and application thereof |
| 01/04/2012 | CN101193858B Inhibitors of neurotrypsin and determination thereof |
| 01/04/2012 | CN101166539B Compositions and methods involving MDA-7 for the treatment of cancer |
| 01/04/2012 | CN101166517B Extrusion process for making compositions with poorly compressible therapeutic compounds |
| 01/04/2012 | CN101163678B Pyridylmethylsulfone derivative |
| 01/04/2012 | CN101163677B Crystalline forms of a biphenyl compound |
| 01/04/2012 | CN101155783B Pyrazoles |
| 01/04/2012 | CN101138543B Centella asiatica partial film forming gel composition and uses thereof |
| 01/04/2012 | CN101094657B Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof |
| 01/04/2012 | CN101085021B Medicinal composition containing safflower and radix astragali, preparation method and preparation |
| 01/04/2012 | CN101068770B Method for producing 6-substituted-1-methyl-1-H-benzimidazole derivative and its production intermediate |
| 01/04/2012 | CN101060844B Combinations of a pyrimidine containing nnrti with rt inhibitors |
| 01/04/2012 | CN101031325B Device for delivering an antimicrobial composition |
| 01/03/2012 | US8088974 Production of polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 01/03/2012 | US8088941 Glycogen synthase kinase-3 inhibitors |
| 01/03/2012 | US8088936 Leukotriene B4 inhibitors |
| 01/03/2012 | US8088935 Compounds and methods for the treatment of asthma |
| 01/03/2012 | US8088934 Composition and method for stabilizing the same |
| 01/03/2012 | US8088930 Benzimidazole derivatives |
| 01/03/2012 | US8088928 Sirtuin modulating compounds |
| 01/03/2012 | US8088926 Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity |
| 01/03/2012 | US8088925 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors |
| 01/03/2012 | US8088921 Method for producing 3-amidinophenylalanine derivatives |
| 01/03/2012 | US8088919 Crystalline forms of pemetrexed diacid and processes for the preparation thereof |
| 01/03/2012 | US8088916 Hyaluronic acid-methotrexate conjugate |
| 01/03/2012 | US8088910 Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region |
| 01/03/2012 | US8088909 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 01/03/2012 | US8088886 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/03/2012 | US8088829 Biocidal aldehyde composition |
| 01/03/2012 | US8088828 Treating benign prostate hyperplasia with SARMS |
| 01/03/2012 | US8088827 Use of irbesartan for the preparation of medicinal products that are useful for treating pulmonary hypertension |
| 01/03/2012 | US8088826 Tetrahydro-naphthalene derivatives |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088824 Forms of CDDO methyl ester |
| 01/03/2012 | US8088823 Tuberculosis treatment using pleuromutilin derivatives |
| 01/03/2012 | US8088822 Use of fenretinide or bioactive derivatives thereof and pharmaceutical compositions comprising the same |
| 01/03/2012 | US8088821 Fused cyclic compounds |